Results 131 to 140 of about 507,226 (409)
Transgender Medicare Beneficiaries and Chronic Conditions: Exploring Fee-for-Service Claims Data.
PURPOSE Data on the health and well-being of the transgender population are limited. However, using claims data we can identify transgender Medicare beneficiaries (TMBs) with high confidence. We seek to describe the TMB population and provide comparisons
Christina N Dragon+3 more
semanticscholar +1 more source
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith+18 more
wiley +1 more source
Prescription Drug Coverage and Elderly Medicare Spending [PDF]
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance -- often unaccounted for in budget estimates -- are the salutary effects that increased prescription drug use might ...
Baoping Shang, Dana P. Goldman
core
The Value of Extra Benefits Offered by Medicare Advantage Plans in 2006 [PDF]
Examines the out-of-pocket savings for average enrollees of private fee-for-service (PFFS) and other Medicare Advantage plans, compared to what they would pay under original Medicare, plus the value of additional services such as dental or vision ...
Mark Merlis
core
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier+20 more
wiley +1 more source
ClinicalLINKS – How to coordinate and integrate between primary, community and hospital-based care
Tiana Maree Gurney+4 more
doaj +3 more sources
This study assessed the use of 35 pharmacogenomic (PGx) medications listed in the Royal College of Pathologists of Australasia (RCPA) guideline, estimated the potential costs of subsidizing PGx testing in Australia, and predicted related prescribing changes.
Bella D. Ianni+3 more
wiley +1 more source
Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta+5 more
wiley +1 more source
Map of Medicine: A change management tool for integration of local health services
Amanda Hese+2 more
doaj +3 more sources